Serious Adverse Events in the Canadian Registry of Children Receiving Palivizumab (CARESS) for Respiratory Syncytial Virus Prevention.

Serious Adverse Events in the Canadian Registry of Children Receiving Palivizumab (CARESS) for Respiratory Syncytial Virus Prevention.

To evaluate the safety and tolerability of palivizumab for RSV prophylaxis in high-risk children in everyday practice.High-risk children prophylaxed against RSV infection were recruited into a prospective, observational, Canadian RSV Evaluation Study of Palivizumab (CARESS) registry with active, ser...

Full description

Bibliographic Details
Main Authors: Jinghan Jenny Chen, Parco Chan, Bosco Paes, Ian Mitchell, Abby Li, Krista L Lanctôt, CARESS investigators
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2015-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4523213?pdf=render

Internet

http://europepmc.org/articles/PMC4523213?pdf=render

Similar Items